Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?
PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.
UiPath: Why Claude-Related Fears Are Grossly Overblown (Earnings Preview)
UiPath, Inc. remains attractively valued after a 24% price drop, with macro and Claude-related fears appearing overblown given recent financial performance. PATH posted Q3 YoY revenue growth of ~16%, first-ever profitable Q3 EBIT, and robust ARR expansion, signaling resilience despite competitive AI threats. Management guides for continued ARR and sales growth in Q4, with a strong track record of beating both guidance and consensus expectations.
UiPath's Debt-Free Balance Sheet Fuels Strategic Flexibility
PATH's debt-free balance sheet and $1.4B cash reserve give it unique flexibility to invest boldly in automation growth.
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath (PATH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
UiPath (PATH) concluded the recent trading session at $10.17, signifying a -5.83% move from its prior day's close.
UiPath Strengthens its Position in the Global Automation Landscape
PATH strengthens its RPA leadership with AI-driven automation and powerful alliances, even as the stock lags and earnings estimates climb.
UiPath (PATH) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, UiPath (PATH) closed at $10.94, indicating a -3.36% shift from the previous trading day.
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
Forget The Current Software Fears: UiPath Combines Software With AI And It Works
UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% YoY revenue growth highlight its resilience and growth trajectory. A pristine balance sheet—$1.4B cash, low liabilities, and high cash flow—supports continued innovation and mitigates dilution risk.
UiPath (PATH) Registers a Bigger Fall Than the Market: Important Facts to Note
UiPath (PATH) closed at $11.7 in the latest trading session, marking a -9.69% move from the prior day.
UiPath: Underperforming Its Peers, But Still Worth Getting Behind
UiPath (PATH) has contracted by 7% over the past year, underperforming both its mid-cap and technology peers that have moved up by double-digits. PATH is well-positioned in the fast-growing agentic AI market, with its enhanced cross-vendor orchestration capabilities. PAT has been trimming its SG&A base very effectively, even as operating margins and cash flow conversion continue to improve.
UiPath Declines 25% in a Month: Has the Buying Level Been Reached Yet?
PATH shares slide 25% in a month despite GAAP profitability, ARR growth and big AI partnerships, prompting a wait-and-watch call.
